Clinical Trials Browser

Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Lymphoma, Melanoma, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Microsatellite Instability, Small Cell Lung Carcinoma

NCT04688749 2023-07-25

DermaSense

Terminated

50 enrolled

DermatologicSarcoma

Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Carcinosarcoma, Dysplastic Nevus Syndrome, Melanoma, Neoplasms, Keratosis, Seborrheic, Hutchinson's Melanotic Freckle

NCT05848219 2023-05-08

Healthcare Resource Utilization and Costs in Metastatic Melanoma Patients Initiated Dabrafenib + Trametinib and Encorafenib + Binimetinib

Terminated

543 enrolled

Dermatologic

Melanoma

NCT05061940 2022-12-06

This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols.

Terminated

22 enrolled

DermatologicHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Melanoma, Neoplasm Metastasis

NCT03464604 2022-11-23

Melanoma Accuracy Study; Phase 2

Terminated

121 enrolled

Dermatologic

Melanoma

NCT00507325 2022-09-02

Sample Collection From Melanoma Patients

Terminated

131 enrolled

Dermatologic

Melanoma, Neoplasms

NCT03407040 2021-11-10

Generation of Cancer Antigen-Specific T-cells From Human Induced Pluripotent Stem Cells (iPSC) for Research and Potential FutureTherapy

Terminated

98 enrolled

BreastDermatologicGastrointestinalThoracic

Breast Neoplasms, Gastrointestinal Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Pancreatic Neoplasms

NCT02355574 2021-10-08

INTEGRATE

Terminated

301 enrolled

Dermatologic

Melanoma

NCT02355587 2021-10-08

EXPAND

Terminated

72 enrolled

Dermatologic

Melanoma

NCT04473027 2021-05-10

BLOOD

Terminated

3 enrolled

Dermatologic

Melanoma, Neoplasms

NCT03727087 2021-02-10

Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Melanoma

Terminated

348 enrolled

Dermatologic

Melanoma

NCT03321903 2019-12-19

EPR Tumor Oximetry With CE India Ink

Terminated

3 enrolled

BreastDermatologicHead & Neck

Anthrax, Breast Neoplasms, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Melanoma, Neoplasms, Skin Neoplasms

NCT02744209 2019-11-07

Immune Predictors of Response to Pembrolizumab Therapy in Stage IV Melanoma Patients

Terminated

17 enrolled

Dermatologic

Melanoma

NCT02900248 2019-04-02

N1

Terminated

23 enrolled

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckMyeloidOther hematologic neoplasmPlasma cellSarcomaThoracic

Anus Neoplasms, Biliary Tract Neoplasms, Urinary Bladder Neoplasms, Brain Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Multiple Myeloma, Myelodysplastic Syndromes, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Sarcoma, Skin Neoplasms, Stomach Neoplasms, Testicular Neoplasms, Endometrial Neoplasms, Hematologic Neoplasms

NCT02339987 2019-02-21